Comparison of Symptom Score, Urinary Flow Rate and Residual Urine :Transurethral Microwave Thermotherapy Versus Alpha-1 Blocker for Benign Prostatic Hyperplasia.
- Author:
Man Soo LEE
1
;
Kwang Soo LEE
Author Information
1. Department of Urology, Seoul Red Cross Hospital, Seoul, Korea.
- Publication Type:Original Article
- Keywords:
prostatic hyperplasia;
thermotherapy;
microwave;
alpha-1 blocker
- MeSH:
Humans;
Hyperthermia, Induced;
Microwaves;
Prostate;
Prostatic Hyperplasia*;
Transurethral Resection of Prostate*
- From:Korean Journal of Urology
1996;37(11):1289-1294
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: We attempt to compare the impact of transurethral microwave thermotherapy (TUMT) with alpha-1 blocker (terazosin) on the symptom score, flow rate and residual urine. MATERIALS AND METHOD: A total of 29 patients underwent TUMT and 20 patients were treated by terazosin. FDA symptom score, urinary flow rate and residual urine before and after therapy were analyzed. RESULTS: Although an improvement in symptom score, flow rate and residual urine was noted at 6 months in both groups, there was no statistic significance between two groups in symptom score and flow rate. Reduction of residual urine only showed marginally significant difference in two groups. CONCLUSION: Except patients with absolute indications for transurethral resection of the prostate (TURP), those with symptomatic benign prostatic hyperplasia (BPH) will be benefited by these two modalities and TUMT is more effective than alpha-1 blocker in reducing residual urine.
